The acute and chronic effects of repeated intravitreal antivascular endothelial growth factor
(VEGF) injections on intraocular pressure have not been fully characterized, and the …

Introduction: Biologics are generally macromolecules, large in size with poor stability in
biological environments. Delivery of biologics to tissues at the back of the eye remains a …

Purpose The aim of this study was to investigate the sustained intraocular pressure (IOP)
elevation after repeated anti-VEGF intravitreal injections (IVI) in patients with diabetic …

Purpose. The assessment of the incidence of ocular hypertension over a period of 1 year in
patients treated with multiple intravitreal injections of anti-VEGF agents for neovascular …

Objective: There is a substantial debate in the ophthalmology community about whether anti-
vascular endothelial growth factor (VEGF) injections result in a long-term increase in …

Intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents are widely
used to treat neovascular age-related macular degeneration (nAMD). Although these …

Abstract Introduction: Intravitreal Avastin (bevacizumab) injection is reportedly accompanied
by ocular and systemic side-effects. Our enquiry assesses whether there are any differences …

Objective: The study's goal is to determine how IOP gets affected following intravitreal
injection of various anti-VEGF for diabetic macular edema (DME) over 2 months duration …

The effect of intravitreal injections for diabetic macular edema on intraocular pressure:
Comparative study Page 1 NEUROQUANTOLOGY | OCTOBER 2022 | VOLUME 20 | ISSUE 11 …

Objetivo: O tratamento com anti-angiogêncios é uma das modalidades mais utilizadas em
patologias relacionadas ao edema macular. A injeção intravítrea de um inibidor do VEGF-A …